title: [Omalizumab in severe asthma--case report].
abstract: We describe the case of 31-year-old woman whose severe asthma was not properly controlled with best available therapy according to GINA (2002). Following administration of anti-IgE monoclonal antibody she experienced significant improvement in her asthma control
authors.affiliation: Klinika Pulmonologii II Katedry Chorób Wewnetrznych CM UJ w Krakowie.
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Gawlewicz-Mroczka
authors.forename: Ewa
authors.initials: E
authors.lastname: Nizankowska-Mogilnicka
mesh_terms: D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069444:Omalizumab; D011788:Quality of Life; D012221:Rhinitis, Allergic, Perennial / Q000150:complications; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab